Clinical Trials Browser

Hematologic Neoplasms × Inotuzumab Ozogamicin × 1 year × Clear all

NCT04307134 2025-12-31

Besponsa Post Marketing Surveillance Study

108 enrolled 39 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hematologic Neoplasms